Your browser doesn't support javascript.
Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours.
Oosting, Sjoukje F; van der Veldt, Astrid A M; Fehrmann, Rudolf S N; GeurtsvanKessel, Corine H; van Binnendijk, Rob S; Dingemans, Anne-Marie C; Smit, Egbert F; Hiltermann, T Jeroen N; den Hartog, Gerco; Jalving, Mathilda; Westphal, Tatjana T; Bhattacharya, Arkajyoti; de Wilt, Faye; Boerma, Annemarie; van Zijl, Lisanne; Rimmelzwaan, Guus F; Kvistborg, Pia; van Els, Cecile A C M; Rots, Nynke Y; van Baarle, Debbie; Haanen, John B A G; de Vries, Elisabeth G E.
  • Oosting SF; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
  • van der Veldt AAM; Department of Medical Oncology, Erasmus Medical Centre, 3015 GD Rotterdam, Netherlands; Department of Radiology and Nuclear Medicine, Erasmus Medical Centre, 3015 GD Rotterdam, Netherlands. Electronic address: a.vanderveldt@erasmusmc.nl.
  • Fehrmann RSN; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
  • GeurtsvanKessel CH; Department of Viroscience, Erasmus Medical Centre, 3015 GD Rotterdam, Netherlands.
  • van Binnendijk RS; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
  • Dingemans AC; Department of Respiratory Medicine, Erasmus Medical Centre, 3015 GD Rotterdam, Netherlands.
  • Smit EF; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Hiltermann TJN; Department of Pulmonary Diseases, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
  • den Hartog G; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
  • Jalving M; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
  • Westphal TT; Netherlands Comprehensive Cancer Organization, Utrecht, Netherlands.
  • Bhattacharya A; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
  • de Wilt F; Department of Viroscience, Erasmus Medical Centre, 3015 GD Rotterdam, Netherlands.
  • Boerma A; Department of Medical Microbiology and Infection Prevention, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
  • van Zijl L; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Rimmelzwaan GF; Research Centre for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Hannover, Germany.
  • Kvistborg P; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • van Els CACM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands; Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.
  • Rots NY; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
  • van Baarle D; Department of Medical Microbiology and Infection Prevention, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
  • Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • de Vries EGE; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
Lancet Oncol ; 23(7): 833-835, 2022 07.
Article in English | MEDLINE | ID: covidwho-1907912
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: 2019-nCoV Vaccine mRNA-1273 / Neoplasms Topics: Vaccines Limits: Humans Language: English Journal: Lancet Oncol Journal subject: Neoplasms Year: 2022 Document Type: Article Affiliation country: S1470-2045(22)00203-0

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: 2019-nCoV Vaccine mRNA-1273 / Neoplasms Topics: Vaccines Limits: Humans Language: English Journal: Lancet Oncol Journal subject: Neoplasms Year: 2022 Document Type: Article Affiliation country: S1470-2045(22)00203-0